Shareholders meeting

Mangalam Drugs and Organics Limited Regd. Office : Rupam Building, 3rd Floor, 239 P. D’Mello Road, Near G. P. 0. Mumbai - 400 001 ® 91-22-62616200 / 63/0 87087 @ 91-22-62619090 e CIN : [24230MH1972PLC116413 “X'::,?;fi:;pl August 31,2026 REF: MDOL/CS-SE/2026-27/0024 To, To, Listing Department Listing Department BSE Ltd National Stock Exchange ofI ndia Limited 15t Floor, New Trade Wing, “Exchange Plaza”, 5t Floor, Phiroze Jeejeebhoy Towers, Plot No. C-1, Block G, Dalal Street, Fort, Bandra - Kurla Complex, Mumbai - 400 001 Bandra (E), Mumbai - 400 051 Scrip Code: 532637 Symbol: MANGALAM Dear Sir/ Madam, Subject: Annual Report of the Company, Notice convening 5374 Annual General Meeting (‘AGM”) for the Financial Year 2025-26 and Intimation of cut-off date for remote e- voting of Mangalam Drugs and Organics Limited (“The Company”): Reference: Pursuant to Regulation 34 read with Regulation 36 and Clause 12 of Part A of Schedule 111 of Securities and Exchange Board of India (“SEBI”) (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”): In furtherance to the captioned subject and mentioned reference, we wish to inform you that 534 AGM of the Company is scheduled to be held on Wednesday, September 2314, 2026, at 03.00 P.M. through Video Conference / Other Audio-Visual Means, in accordance, with the relevant circulars issued by Ministry of Corporate Affairs and SEBI. Please find enclosed Annual Report of the Company for the Financial Year 2025-26 including Notice convening the 53rd AGM. In compliance with relevant circulars issued by Ministry of Corporate Affairs and the SEBI, the Annual Report of the Company for the Financial Year 2025-26 including Notice convening the 534 AGM is being sent through electronic mode to all the Members of the Company whose Email addresses are registered with the Company or Registrar & Share Transfer Agent of the Company or Depository Participant(s). We wish to bring to your kind notice the schedule of the 53r4 AGM of the Company for the Financial Year 2025-26 as under: Factory : at Vapi (Gujarat) India @ contactus@mangalamdrugs.com @ http://www.mangalamdrugs.com Mangalam Drugs and Organics Limited MANGALAM Regd. Office : Rupam Building, 3rd Floor, 239 P. D'Mello Road, Near G. P. 0. Mumbai - 400 001 h__d ® 91-22-62616200 / 6300 / 8787 @ 91-22-62619090 CIN : L24230MH1972PLC116413 WHOCMP Particulars B ' Details W Date of 53rd AGM September 2314, 2026 Day of 5311 AGM B Wednesday Time of 5311 AGM 03:00 P.M. (LS.T.) Mode of 5371 AGM - Video Conferencing / Other Audio-visual Means Participation through video conferencing | As provided in Notice of 53rd AGM Cut-off date for e-voting September 16, 2026 (Wednesday) E-Voting start date and time September 19, 2026 (Saturday) at 09:00 A.M. E-Voting end date and time September 22, 2026 (Tuesday) at 05:00 P.M. The Annual Report including Notice of AGM for the Financial Year 2025-26 is also being made available on the website of the Company at: https://www.mangalamdrugs.c content/uploads/2026/08 /mdolannualreport2026.pdf and this is also available on the website of NSDL at www.evoting.nsdl.com. We request you to take the above on your record. Thanking You, Yours faithfully For and on Behaloff Mangalam Drugs & Organics Limited Govardhan M. Dhoot Managing Director DIN: 01240086 Factory : at Vapi (Gujarat) India & contactus@mangalamdrugs.com @ http://www.mangalamdrugs.com MANGALAM DRUGS & ORGANICS LIMITED https://www.mangalamdrugs.com/wp-content/uploads/2026/08/mdolannualreport2026.pdf ANNUAL REPORT 2025-2026 50th Mangalam Drugs & Organics Limited 3rd Floor, Rupam Building, 239, P.D’ Mello Road, Near G.P.O., 2 0 22 - 23 Mumbai 400001. MANGALAM DRUGS & ORGANICS LIMITED Notice Boards' Report Corporate Governance Report Financial Statements CORPORATE INFORMATION BOARD OF DIRECTORS AND KEY MANAGERIAL PERSONNEL Name Of Directors / KMP Current Designation Appointment Cessation DIN / PAN Shri Govardhan Murlidhar Dhoot Chairman & Managing Director 16/04/1996 - 01240086 Shri Brijmohan Murlidhar Dhoot Whole-Time Director 02/05/2015 - 01046420 Smt. Nidhi Shantanu Mundada Independent Director 28/05/2018 - 08134952 Shri Praveen Saxena Independent Director 21/03/2021 - 03199264 Shri Rukmesh P. Dhandhania Independent Director* 20/11/2017 16/01/2026 02493968 Shri Rakesh Kishinchand Milwani Non-Executive Director 10/03/2022 - 01115469 Shri Ajay Avinash Samant Chief Financial Officer** 31/10/2014 31/01/2026 *****1380A Shri Jeevan Dalvi Chief Financial Officer 06/02/2026 *****1231M Smt. Anuradha Pandey Company Secretary*** 08/07/2024 29/03/2026 *****4763C Smt. Shweta Patel Company Secretary 01/04/2026 *****5846L *Shri Rukumesh Dhandhaniya resigned on 16/01/2026 **Shri Ajay Avinash Samant resigned on 31/01/2026 *** Smt. Anuradha Pandey resigned on 29/03/2026 AUDITORS Sr. Particulars of Statutory Auditor Internal Auditor Secretarial Auditor Cost Auditor No. Details Ragini Chokshi & Co. V. S. Somani & Co. Bipin Zavar & Associates Rampurawala Mohammed A & Co. 1. Name Practicing Company Chartered Accountants Chartered Accountants Cost Accountants Secretaries 2. FRN / M. No / CP No 117589W 121523W 92897 003011 3. Date of Appointment 24/09/2021 14/05/2026 29/09/2025 14/05/2026 4. Appointed in 48th AGM* Board Meeting 52nd AGM** Board Meeting 5. Tenure 5 Years 1 Year 5 Year 1 Year *M/s S.N. Nanda & Co., Chartered Accountants (FRN: 000685N) shall be appointed as the Statutory Auditor of the Company for term of 5 years (from conclusion of 53rd AGM to 58th AGM), subject to consent of members at the ensuing 53rd Annual General Meeting (AGM), upon completion of the term of M/S V.S. Somani & Co., Chartered Accountants. **Appointment of M/s L.N. Joshi & Co, Practicing Company Secretaries (CPN: 4216) as the Secretarial Auditor of the Company for term of 5 years (from conclusion of 53rd AGM to 58th AGM), subject to consent of members at the ensuing 53rd Annual General Meeting (AGM) pursuant to resignation of M/s Ragini Chokshi & Co. Practicing Company Secretaries Listed on Stock Exchange: 1. National Stock Exchange of India Limited and Bombay Stock Exchange Limited. OFFICE DETAILS Registered Office Unit 1 Unit 2 239, Rupam Building, 3rd Floor, P. D’ Mello Road, Near G.P.O., Mumbai – 400001, MH- India Tel No. 91-22-62616200/6300/8787 Fax No. 91-22-62619090 Plot No. 187, GIDC Vapi, Plot No. 1203, GIDC Vapi, E-mail: contactus@mangalamdrugs.com Dist. Valsad Dist. Valsad, Gujarat – 396 195 Gujarat – 396 195 Investors’ E-mail Id: investor@mangalamdrugs.com Website: http://www.mangalamdrugs.com OTHER DETAILS Bankers Registrar & Share Transfer Agent  State Bank of India MUFG Intime India Private Limited Address: C – 101, 247 Park, L.B.S. Marg, Vikhroli (West), Mumbai – 400083, MH, India  Bank of Maharashtra Tel No.: 91-22-49186000  Bank of Baroda Email: mumbai@in.mpms.mufg.com 53rd Annual Report 2025-26 MANGALAM DRUGS & ORGANICS LIMITED TABLE OF CONTENTS: Sr. No. Item Page No 1. Notice of 53rd Annual General Meeting (AGM) 2. Directors’ Report Annexure – A T he statement containing salient features of the Financial Statement of Subsidiaries / Associate Companies / Joint Ventures Annexure – B Conservation of Energy, Technology Absorption and Foreign Exchange Earnings and Outgo. Annexure – C Secretarial Audit Report (Form MR. 3). Annexure – D Secretarial Annual Compliance Report. Annexure – E Management Discussion and Analysis Report Annexure – F Particulars of Employees & Remuneration of Directors and Key Managerial Personnel Annexure – G Corporate Governance Report 3. Standalone Auditor's Report and Financial Statements for the Financial Year 2025-2026 4. Consolidated Auditor's Report and Financial Statements for the Financial Year 2025-2026 53rd Annual Report 2025-26 Notice Boards' Report Corporate Governance Report Financial Statements TO SHAREHOLDERS Respected Shareholders, It is my privilege to present to you the Annual Report for Financial Year 2025–26 of your Company, with both pride in [Showing first 8,000 characters — download PDF for full document]